Continuing Education Online

Health Equity and Disability Issues in Diabetes Care

Trisha Menon, MD, and Alyson K. Myers, MD

Health equity is achieved when every person has the opportunity to “attain his or her full health potential” and no one is “disadvantaged from achieving this potential because of social position or other socially determined circumstance.” Equity for people with diabetes is created and maintained by providers, health systems, and community, and fractures in such systems lead in inequity. This article presents the health barriers in achieving health equity in diabetes care and steps the case manager can address in overcoming those barriers. 

This supplement was supported by an unrestricted grant from Abbott Diabetes Care.

Exam expires September 1, 2023.

Click here to take the exam online.

Prefer to print the supplement and exam? Download and view/print a pdf.

Celebrate National Diabetes Month by learning about improving outcomes of patients with diabetes using continuous glucose monitoring. Thirty-four million Americans have diabetes and there is an expected 26% increase over the next five years. The annual financial impact of diabetes is $327 Billion with people who have diabetes having 2.3 times greater health care costs. One out of every seven healthcare dollars is spent treating diabetic patients.

As a case manager, you can make a difference! This continuing education program provides you with knowledge about continuous glucose monitors including types, how they work, patient selection criteria and how they can help control blood glucose levels in your patients including your role and responsibility.

This supplement was supported by an unrestricted grant from Abbott Diabetes Care.

Exam expires November 15, 2022.

Prefer to print the supplement and exam? Download and view/print a pdf.

Fatty liver disease (steatosis) is the storage of excessive fat in the liver and has an increasing incidence. A healthy liver is essential because of the many bodily functions it supports. It is important for the case manager to understand and be knowledgeable about fatty liver disease because there is no approved drugs for treatment. Current treatment consists of lifestyle changes. This supplement covers pathophysiology of nonalcoholic fatty liver disease, signs and symptoms, associated comorbidities and managing the disease along with the role and responsibilities of the case manager.

This supplement is supported by an educational grant from Theratechnologies Inc.

Exam expires October 15, 2022.

Prefer to print the supplement and exam? Download and view/print a pdf.

Earn 2 FREE CEUs of of Nursing credits through this special supplement supported by ChemoCentryx, Inc.

By Curry L. Koening, MD, MS and Irene von Hennigs, PharmD

ANCA-associated vasculiides are a group of rare, life-threatening autoimmune disorders that are characterized by a necrotizing inflammatory process predominantly affecting small and medium-seized blood vessels. The inflammatory process care have serve clinical consequences and can be life-threatening. In this soon to be published self-study supplement, you will learn how the disease is defined and classified, pathophysiology, clinical manifestations, current treatments and future treatment options. When diagnosed early and treated properly current therapies for ANCA vasculitis can be successful in reducing and preventing organ damage. The knowledge obtained from completing this self-study continuing education approved course will help you improve your patients with ANCA vasculitis outcomes.

This publication was supported by ChemoCentryx, Inc.

Exam expires September 15, 2022.

Prefer to print the supplement and exam? Download and view/print a pdf.